tert-Butyl ((5-(aminomethyl)pyridin-2-yl)methyl)carbamate, 95%, 50mg

Boc-N-Me-Phe-OH, 95.0%, 1g

Diflubenzuron>95.0%(HPLC)25g

N-(2-Amino-2-phenylethyl)-N,N-dimethylamine, 95.0%, 1g

(S)-N-(1-Hydroxy-3-phenylpropan-2-yl)acetamide, 97.0%, 1g

N-(5-(3-(7-(3-FLUOROPHENYL)-3H-IMIDAZO[4,5-C]PYRIDIN-2-YL)-1H-INDAZOL-5-YL)PYRIDIN-3-YL)-3-METHYLBUTANAMIDE, 95%, 50mg

N,N'-((1R,2R)-cyclohexane-1,2-diyl)dimethanesulfonamide, 95.0%, 100mg

Ethyl 4-oxo-3,4-dihydrothieno[3,2-d]pyrimidine-2-carboxylate, 95.0%, 1g

N-Boc-L-4'-Tetrahydropyranylglycine, 95.0%, 250mg

Combretastatin A4, 98.0%, 5mg

TERT-BUTYL 3-BROMO-6-CYANO-1H-INDOLE-1-CARBOXYLATE, 95%, 5g

TERT-BUTYL (4S)-3,3-DIFLUORO-4-HYDROXYPYRROLIDINE-1-CARBOXYLATE, 95%, 5g

[(1S,3S,4S)-4-Amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]carbamic acid 1,1-dimethyl ethyl ester, 95.0%, 10g